3-(2,2,2-trimethylhydrazine)propionate and Ventricular Fibrillation

3-(2,2,2-trimethylhydrazine)propionate has been researched along with Ventricular Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, Y; Kirimoto, T; Matsuura, N; Miyake, H; Tajima, K	1

Other Studies

1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Ventricular Fibrillation

Article	Year
Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts. Pharmacology, 2000, Volume: 61, Issue:4 Topics: Animals; Carnitine; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart Function Tests; Hemodynamics; In Vitro Techniques; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation	2000

Article

Year

Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.

Pharmacology, 2000, Volume: 61, Issue:4

Topics: Animals; Carnitine; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart Function Tests; Hemodynamics; In Vitro Techniques; Lactic Acid; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation

2000